The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis
暂无分享,去创建一个
M. Stegall | M. Schnitzler | D. Gerber | M. Rees | R. Pelletier | D. Segev | R. Montgomery | M. Melcher | S. Kapur | J. Roberts | D. Axelrod | A. Massie | Xun Luo | K. Lentine | L. Ratner | J. Oberholzer | T. Dunn | M. Cooper | D. Sudan | S. Jordan | R. Shapiro | C. Marsh | A. Bozorgzadeh | B. Orandi | G. Lipkowitz | M. Posner | J. Garonzik-Wang | J. Wellen | P. W. Nelson | Huiling Xiao | A. Osama Gaber | P. Singh | J. El-Amm | B. Sankari | H. Xiao | X. Luo | J. Garonzik‐Wang | M. Schnitzler | R. A. Montgomery | David A. Axelrod | Debra L. Sudan | Jose Oberholzer | John P. Roberts | Lloyd E. Ratner | Stanley C. Jordan | Ty B. Dunn | Sandip Kapur | Ronald P. Pelletier | Pooja Singh | Ron Shapiro | Michael A. Rees | Christopher L. Marsh | David A. Gerber | Marc L. Melcher | Marc P. Posner | Paul W. Nelson | Adel Bozorgzadeh | A. O. Gaber
[1] M. Schnitzler,et al. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] D. Segev,et al. Early Changes in Kidney Distribution under the New Allocation System. , 2016, Journal of the American Society of Nephrology : JASN.
[3] M. Stegall,et al. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. , 2016, The New England journal of medicine.
[4] S. Jordan,et al. Modern approaches to incompatible kidney transplantation. , 2015, World journal of nephrology.
[5] S. Jordan,et al. Achieving incompatible transplantation through desensitization: current perspectives and future directions. , 2015, Immunotherapy.
[6] R. Alloway,et al. Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] A. Vo,et al. Benefits, efficacy, cost‐effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti‐CD20 therapy , 2014, Clinical and experimental immunology.
[8] D. Segev,et al. Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation , 2014, Transplantation.
[9] D. Fanoni,et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome , 2014, Clinical and experimental immunology.
[10] M. Schnitzler,et al. Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients , 2014, Transplantation.
[11] M. Stegall,et al. Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] R. Alloway,et al. Desensitization in kidney transplantation: review and future perspectives , 2014, Clinical transplantation.
[13] J. Petrozzino,et al. Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab , 2013, Transplantation.
[14] M. Stegall,et al. Five‐Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] D. Segev. Innovative strategies in living donor kidney transplantation , 2012, Nature Reviews Nephrology.
[16] Nathan T. James,et al. Outcomes of ABO-Incompatible Kidney Transplantation in the United States , 2012, Transplantation.
[17] A. Bello,et al. Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] L. Kucirka,et al. Incompatible live-donor kidney transplantation in the United States: results of a national survey. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[19] L. Kucirka,et al. Desensitization in HLA-incompatible kidney recipients and survival. , 2011, The New England journal of medicine.
[20] S. Jordan,et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. , 2008, The New England journal of medicine.
[21] S. Jordan,et al. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. , 2009, Contributions to nephrology.
[22] Eld,et al. COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT , 2000 .